A Web-based, Mobile Responsive Application to Screen Healthcare Workers for COVID Symptoms: Descriptive Study

Zhang, Haipeng; Dimitrov, Dimitar; Simpson, Lynn; Singh, Balaji; Plaks, Nina; Penny, Steve; Charles, Joseph O.; Sheehan, Rose; Flammini, Steve; Murphy, Shawn N.; Landman, Adam B.

doi:10.1101/2020.04.17.20069211

Cited by 20 publications

(17 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Large employers both in the healthcare and non-healthcare spaces should consider enacting similar tools and processes. Although others have described their initial experience implementing entry screening tools, [18] this is to our knowledge the first and most longitudinal peer-reviewed data on a commercially-available employee COVID-19 screening tool.…”

Section: Discussionmentioning

confidence: 99%

Implementation of a digital chatbot to screen health system employees during the COVID-19 pandemic

Judson

Odisho

Young

et al. 2020

Journal of the American Medical Informatics Association

102

View full text Add to dashboard Cite

SUMMARY The screening of healthcare workers for COVID-19 symptoms and exposures prior to every clinical shift is important for preventing nosocomial spread of infection but creates a major logistical challenge. To make the screening process simple and efficient, UCSF Health designed and implemented a digital chatbot-based workflow. Within one week of forming a team, we conducted a product development sprint and deployed the digital screening process. In the first two months of use, over 270,000 digital screens have been conducted. This process has reduced wait times for employees entering our hospitals during shift changes, allowed for physical distancing at hospital entrances, prevented higher-risk individuals from coming to work, and provided our healthcare leaders with robust, real-time data for make staffing decisions.

show abstract

Section: Discussionmentioning

confidence: 99%

Implementation of a digital chatbot to screen health system employees during the COVID-19 pandemic

Judson

Odisho

Young

et al. 2020

Journal of the American Medical Informatics Association

102

View full text Add to dashboard Cite

show abstract

“…Recently, during the outbreaks of Ebola and Severe Acute Respiratory Syndrome (SARS), mHealth applications exhibited its potential in screening, detecting, and monitoring such global epidemics [ 14 , 22 , 23 ]. Mobile health technologies and applications have been utilized in this current COVID-19 pandemic and other infectious diseases in most HICs as compared to LMICs [ 24 , 25 , 26 ]. Currently, a study in Canada has revealed that mHealth applications have been utilized for screening, diagnosis, and monitoring of COVID-19 cases [ 14 ].…”

Section: Overviewmentioning

confidence: 99%

Mobile health applications for disease screening and treatment support in low-and middle-income countries: A narrative review

Osei

Mashamba-Thompson

2021

Heliyon

View full text Add to dashboard Cite

The advances in mobile technologies and applications are driving the transformation in health services delivery globally. Mobile phone penetration is increasing exponentially in low-and middle-income countries, hence using mobile phones for healthcare services could reach more people in resource-limited settings than the traditional forms of healthcare provision. The review presents recent literature on facilitators and barriers of implementing mHealth for disease screening and treatment support in low-and middle-income countries. We searched for relevant literature from the following electronic databases: MEDLINE; CINAHL with full text via EBSCOhost; Science Direct; PubMed; Google Scholar and Web of Science using the keywords for relevant studies. We searched for published studies from 2015 to August 2020 with no language limitations. A total of 721 articles identified, 125 articles met the inclusion criteria and were included in the qualitative synthesis. The review demonstrates relevant facilitators for the implementation of mHealth, which includes knowledge, attitudes, and perceptions of stakeholders on the use of mHealth and the performance of mHealth for disease diagnosis in low and-middle-income countries. Barriers and challenges hindering the implementation of mHealth applications were also identified. We proposed a framework for improving the implementation of mHealth for disease screening and treatment support in low-and middle-income countries.

show abstract

“…Commercially available electronic patient-reported outcome (ePRO) platforms were examined to determine their clinical utility and potential implementation during the COVID-19 pandemic. Figure 4 shows an example of the ePRO platform for COVID-19 self-reports [19]. Twelve systems were analyzed.…”

Section: Approach To Identify Suitable Mhealth Technologiesmentioning

confidence: 99%

“…Screenshot of the platform currently utilized by MGB to collect self-reports of COVID-19 symptoms. Image reproduced with permission from Ref [19]…”

mentioning

confidence: 99%

Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products

Jorfi

Luo²,

Hazra

et al. 2020

Preprint

View full text Add to dashboard Cite

As the United States prepares to return to work and open up the economy in the midst of the COVID-19 pandemic without an available vaccine or effective therapy, testing and contact tracing are essential to contain and limit the spread of the COVID-19 virus. In response to the urgent public health need for accurate, effective, low-cost, and scalable COVID-19 testing technology, we evaluated and identified diagnostic solutions with potential for use as an at-home product. We conducted a deep horizon scan for antigen and serology-based diagnostics and down-selected to the most promising technologies. A total of 303 candidate products (138 antibody and 44 antigen tests) were identified. Product evaluations were based entirely on company-provided data. 73 serology-based antibody tests passing an initial scoring algorithm based on specificity and sensitivity data were then further evaluated using a second scoring algorithm. This second algorithm included a review of additional technical specifications of the devices, an analysis of supply chain, manufacturing, and distribution capacity of each vendor. 24 potential antibody products met the selection criteria for further direct laboratory evaluation. The performance metrics for selection of these 24 products are currently being evaluated in a Mass General Brigham laboratory. Testing alone might not be sufficient to prevent the spread of a highly contagious disease like COVID-19. Manual contact tracing could complement testing, but it is likely to fail in identifying many individuals who were in contact with a given COVID patient. The proliferation of smartphones in the population has enabled the development of solutions that can provide public health officials with valuable information for rapid and accurate contact tracing. Besides, electronic-based contact tracing solutions can be augmented by symptom self-reports gathered using electronic patient reported outcome (ePRO) platforms and by physiological data collected using wearable sensors. We performed a detailed assessment of 12 ePRO solutions, 27 wearable sensors, and 44 electronic-based contact tracing solutions. These technologies were evaluated using criteria developed to assess their suitability to address the COVID-19 pandemic. We identified a number of solutions that could augment if not provide a more effective alternative to manual contact tracing. Finally, we propose a theoretical framework in which ePRO platforms, wearable sensors, and electronic-based contact tracing solutions would be utilized in combination with molecular and serological tests to identify and isolate COVID-19 cases rapidly.

show abstract

A Web-based, Mobile Responsive Application to Screen Healthcare Workers for COVID Symptoms: Descriptive Study

Cited by 20 publications

References 4 publications

Implementation of a digital chatbot to screen health system employees during the COVID-19 pandemic

Implementation of a digital chatbot to screen health system employees during the COVID-19 pandemic

Mobile health applications for disease screening and treatment support in low-and middle-income countries: A narrative review

Diagnostic technology for COVID-19: comparative evaluation of antigen and serology-based SARS-CoV-2 immunoassays, and contact tracing solutions for potential use as at-home products

Contact Info

Product

Resources

About